UV Flu Technologies Inc
UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product lin… Read more
UV Flu Technologies Inc (UVFT) - Total Liabilities
Latest total liabilities as of March 2016: $783.89K USD
Based on the latest financial reports, UV Flu Technologies Inc (UVFT) has total liabilities worth $783.89K USD as of March 2016.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
UV Flu Technologies Inc - Total Liabilities Trend (2007–2015)
This chart illustrates how UV Flu Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
UV Flu Technologies Inc Competitors by Total Liabilities
The table below lists competitors of UV Flu Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vetanova Inc
PINK:VTNA
|
USA | $2.69 Million |
|
CITIC PACIFIC
BE:CPF
|
Germany | €11.03 Trillion |
|
Roadside Real Estate plc
LSE:ROAD
|
UK | GBX24.87 Million |
Liability Composition Analysis (2007–2015)
This chart breaks down UV Flu Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UV Flu Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UV Flu Technologies Inc (2007–2015)
The table below shows the annual total liabilities of UV Flu Technologies Inc from 2007 to 2015.
| Year | Total Liabilities | Change |
|---|---|---|
| 2015-09-30 | $849.85K | -7.05% |
| 2014-09-30 | $914.30K | +195.67% |
| 2013-09-30 | $309.23K | +96.73% |
| 2012-09-30 | $157.19K | -47.07% |
| 2011-09-30 | $296.97K | -57.06% |
| 2010-09-30 | $691.64K | +13838.71% |
| 2009-09-30 | $4.96K | +458.16% |
| 2008-09-30 | $889.00 | -85.38% |
| 2007-09-30 | $6.08K | -- |